See also this year's filing and all EDGAR filings for this company.
PDF Report 0001516551_2021_Skye_Bioscience_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001516551, Skye Bioscience Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,664,385 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 7,341 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 787,199 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,433,741 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,318,098 |
| 9 | ResearchAndDevelopmentExpense | 1,977,865 |
| 10 | remainder_Expenses | 1,600 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 4,600,553 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,671,726 |
| 1 | Liabilities | 2,220,940 |
| 2 | Expenses | 6,297,563 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 450,786 |
| 5 | NetIncome | -1,697,010 |
| 6 | ComprehensiveNetIncome | -1,697,010 |
| 7 | BaseVar | 7,895,391 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.292 |
| 9 | EconomicCapitalRatio | 1.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
